Evidence map›Paper›PMID 24624337›Full record

ArticleRedox biology2014

Resolution of oxidative stress by thioredoxin reductase: Cysteine versus selenocysteine.

Brian Cunniff, Gregg W Snider, Nicholas Fredette, Jason Stumpff, Robert J Hondal, Nicholas H Heintz

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Engineered mRNA-ribosome fusions for facile biosynthesis of selenoproteins.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. A Diselenide Turn-On Fluorescent Probe for the Detection of Thioredoxin Reductase.Angewandte Chemie (International ed. in English) · 2020
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Brian CunniffDepartment of Pathology, University of Vermont College of Medicine, 149 Beaumont Avenue, Burlington, VT 05405, USA ; Vermont Cancer Center, University of Vermont College of Medicine, Burlington, VT 05405, USA.
Gregg W SniderDepartment of Biochemistry, University of Vermont College of Medicine, Burlington, VT 05405, USA.
Nicholas FredetteDepartment of Pathology, University of Vermont College of Medicine, 149 Beaumont Avenue, Burlington, VT 05405, USA ; Department of Biochemistry, University of Vermont College of Medicine, Burlington, VT 05405, USA.
Jason StumpffDepartment of Molecular Physiology and Biophysics, University of Vermont College of Medicine, Burlington, VT 05405, USA ; Vermont Cancer Center, University of Vermont College of Medicine, Burlington, VT 05405, USA.
Robert J HondalDepartment of Pathology, University of Vermont College of Medicine, 149 Beaumont Avenue, Burlington, VT 05405, USA ; Department of Biochemistry, University of Vermont College of Medicine, Burlington, VT 05405, USA.
Nicholas H HeintzDepartment of Pathology, University of Vermont College of Medicine, 149 Beaumont Avenue, Burlington, VT 05405, USA ; Vermont Cancer Center, University of Vermont College of Medicine, Burlington, VT 05405, USA.
University of Vermont · US

Funding

The Biological and Chemical Function of Selenium in EnzymesR01GM094172 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HONDAL, ROBERT J · 2010 to 2013
$1.3M
NIGMS NIH HHS R01 GM094172
6 · The paper itself

Abstract

Thioredoxin reductase (TR) catalyzes the reduction of thioredoxin (TRX), which in turn reduces mammalian typical 2-Cys peroxiredoxins (PRXs 1-4), thiol peroxidases implicated in redox homeostasis and cell signaling. Typical 2-Cys PRXs are inactivated by hyperoxidation of the peroxidatic cysteine to cysteine-sulfinic acid, and regenerated in a two-step process involving retro-reduction by sulfiredoxin (SRX) and reduction by TRX. Here transient exposure to menadione and glucose oxidase was used to examine the dynamics of oxidative inactivation and reactivation of PRXs in mouse C10 cells expressing various isoforms of TR, including wild type cytoplasmic TR1 (Sec-TR1) and mitochondrial TR2 (Sec-TR2) that encode selenocysteine, as well as mutants of TR1 and TR2 in which the selenocysteine codon was changed to encode cysteine (Cys-TR1 or Cys-TR2). In C10 cells endogenous TR activity was insensitive to levels of hydrogen peroxide that hyperoxidize PRXs. Expression of Sec-TR1 increased TR activity, reduced the basal cytoplasmic redox state, and increased the rate of reduction of a redox-responsive cytoplasmic GFP probe (roGFP), but did not influence either the rate of inactivation or the rate of retro-reduction of PRXs. In comparison to roGFP, which was reduced within minutes once oxidants were removed reduction of 2-Cys PRXs occurred over many hours. Expression of wild type Sec-TR1 or Sec-TR2, but not Cys-TR1 or TR2, increased the rate of reduction of PRXs and improved cell survival after menadione exposure. These results indicate that expression levels of TR do not reduce the severity of initial oxidative insults, but rather govern the rate of reduction of cellular factors required for cell viability. Because Sec-TR is completely insensitive to cytotoxic levels of hydrogen peroxide, we suggest TR functions at the top of a redox pyramid that governs the oxidation state of peroxiredoxins and other protein factors, thereby dictating a hierarchy of phenotypic responses to oxidative insults.

Indexed as

AnimalsCell SurvivalCysteineEpithelial CellsGlucose OxidaseHumansHydrogen PeroxideLungMiceOxidative StressPeroxiredoxinsSelenocysteineThioredoxin Reductase 1Thioredoxin Reductase 2Vitamin K 3CysteineGlucose OxidaseHydrogen PeroxidePeroxiredoxinsSelenocysteineThioredoxin Reductase 1Thioredoxin Reductase 2Vitamin K 3Hydrogen peroxideMenadionePeroxiredoxinsRedox signaling

Identifiers

PMID24624337
PMCPMC3949094
OpenAlexW2021165598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.